UA10681U - Способ лечения больных вегетососудистой дистонией по гипертоническому типу - Google Patents
Способ лечения больных вегетососудистой дистонией по гипертоническому типу Download PDFInfo
- Publication number
- UA10681U UA10681U UAU200505342U UAU200505342U UA10681U UA 10681 U UA10681 U UA 10681U UA U200505342 U UAU200505342 U UA U200505342U UA U200505342 U UAU200505342 U UA U200505342U UA 10681 U UA10681 U UA 10681U
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- treatment
- neurangiosis
- vegetative
- effect
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 25
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 16
- 238000000838 magnetophoresis Methods 0.000 claims abstract description 8
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims abstract description 8
- 238000011282 treatment Methods 0.000 claims description 12
- 230000001631 hypertensive effect Effects 0.000 claims description 10
- 208000014094 Dystonic disease Diseases 0.000 claims description 6
- 208000010118 dystonia Diseases 0.000 claims description 6
- 238000012876 topography Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000001624 sedative effect Effects 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010019196 Head injury Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000003016 hypothalamus Anatomy 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 229910052704 radon Inorganic materials 0.000 description 2
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 206010003074 arachnoiditis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000004887 epithelial permeability Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000000978 myorelaxation Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008756 pathogenetic mechanism Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000004189 reticular formation Anatomy 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Abstract
Способ лечения больных вегетососудистой дистонией по гипертоническому типу предусматривает применение магнитотерапии. Больным выполняют магнитофорез 10% раствора бромида натрия.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200505342U UA10681U (ru) | 2005-06-06 | 2005-06-06 | Способ лечения больных вегетососудистой дистонией по гипертоническому типу |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200505342U UA10681U (ru) | 2005-06-06 | 2005-06-06 | Способ лечения больных вегетососудистой дистонией по гипертоническому типу |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA10681U true UA10681U (ru) | 2005-11-15 |
Family
ID=74506130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU200505342U UA10681U (ru) | 2005-06-06 | 2005-06-06 | Способ лечения больных вегетососудистой дистонией по гипертоническому типу |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA10681U (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2523557C2 (ru) * | 2010-07-15 | 2014-07-20 | Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" | Способ лечения вегетососудистой дистонии и фармацевтическая композиция для лечения вегетососудистой дистонии |
-
2005
- 2005-06-06 UA UAU200505342U patent/UA10681U/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2523557C2 (ru) * | 2010-07-15 | 2014-07-20 | Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" | Способ лечения вегетососудистой дистонии и фармацевтическая композиция для лечения вегетососудистой дистонии |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hendawy et al. | Postoperative analgesic efficacy of ear acupuncture in patients undergoing abdominal hysterectomy: a randomized controlled trial | |
| Kold et al. | Modulation of central pain mechanisms using high‐definition transcranial direct current stimulation: A double‐blind, sham‐controlled study | |
| Urba | Nonpharmacologic pain management in terminal care | |
| Choudhary et al. | Threshold adjusted vagus nerve stimulation after asphyxial cardiac arrest results in neuroprotection and improved survival | |
| RU2486931C1 (ru) | Способ лечения детей с перинатальным поражением центральной нервной системы и его последствий | |
| UA10681U (ru) | Способ лечения больных вегетососудистой дистонией по гипертоническому типу | |
| Zare et al. | The effect of thermal therapy on uremic pruritus in hemodialysis patients | |
| RU2308986C1 (ru) | Способ лечения функциональных нарушений толстой кишки | |
| Wang et al. | Effects of varying acupuncture manipulations at ST36 (zusanli) on gastric electrical frequency and amplitude in bradygastria rabbits | |
| RU2609060C1 (ru) | Способ лечения больных сахарным диабетом 2 типа | |
| RU2451530C1 (ru) | Способ лечения больных хроническим некалькулезным холециститом | |
| RU2778603C1 (ru) | Способ стимуляции резорбции грыжи поясничного отдела позвоночника | |
| RU2709614C1 (ru) | Способ лечения энцефалопатии | |
| RU2714296C1 (ru) | Способ лечения больных с хронической инсомнией | |
| RU2355439C2 (ru) | Способ лечения больных с неврологическими проявлениями дорсопатии | |
| RU2441682C1 (ru) | Способ лечения синдромов зависимости | |
| RU2372888C1 (ru) | Способ курортной терапии больных в раннем восстановительном периоде после легкой черепно-мозговой травмы | |
| Xuereb | Repetitive transcranial magnetic stimulation in Malta: a revolutionary therapy for psychiatric and neurological disorders | |
| RU2566926C1 (ru) | Способ лечения гиперлипидемии | |
| RU2081637C1 (ru) | Способ воздействия на психиатрические и психоневрологические способности организма | |
| RU2148984C1 (ru) | Способ лечения хронического панкреатита | |
| RU2202331C2 (ru) | Способ комплексного лечения вегетативно-сосудистых кризов у взрослых больных, страдающих неврозами | |
| Sun et al. | The Application Progress of Auricular Therapy in Diabetes. | |
| RU2523634C1 (ru) | Способ комплексного воздействия на нервно-рефлекторные механизмы зуда у больных атопическим дерматитом | |
| RU2285552C2 (ru) | Способ лечения алкоголизма |